Silence Therapeutics PLC
OTC:SLNCF
Income Statement
Earnings Waterfall
Silence Therapeutics PLC
Income Statement
Silence Therapeutics PLC
| Dec-2019 | Jun-2020 | ||
|---|---|---|---|
| Revenue | |||
| Revenue |
0
N/A
|
1
+470%
|
|
| Operating Income | |||
| Operating Expenses |
(23)
|
(29)
|
|
| Selling, General & Administrative |
(10)
|
(10)
|
|
| Research & Development |
(13)
|
(18)
|
|
| Operating Income |
(23)
N/A
|
(27)
-20%
|
|
| Pre-Tax Income | |||
| Interest Income Expense |
(0)
|
1
|
|
| Pre-Tax Income |
(23)
N/A
|
(27)
-16%
|
|
| Net Income | |||
| Tax Provision |
3
|
4
|
|
| Income from Continuing Operations |
(20)
|
(22)
|
|
| Net Income (Common) |
(20)
N/A
|
(22)
-14%
|
|
| EPS (Diluted) |
-0.25
N/A
|
-0.28
-12%
|
|